Hepatitis :: Acute Viral Hepatitis Cases Down in US

The three most common forms of acute viral hepatitis in the United States ? hepatitis A, B and C ? declined dramatically between 1995 and 2005, with hepatitis A and B at the lowest levels ever recorded since the government began collecting surveillance data more than 40 years ago, according to the Centers for Disease Control and Prevention (CDC). Hepatitis B and C are diseases that can lead to liver cancer and death.

Tumor :: Mechanisms involved with tumor relapse identified

Researchers at Virginia Commonwealth University?s Massey Cancer Center studying the interaction between the immune system and cancer cells have identified interferon gamma as one of the signaling proteins involved with tumor relapse.

Immunization :: Parental issues interfere with important child immunizations

Nearly 25 percent of children at age two in Hawaii are not sufficiently immunized, and a new study published in the Journal of the American Academy of Nurse Practitioners explored reasons why children were not up to date with their shots. Dr. Niederhauser and her study team spent over 15 hours in the community talking with parents of under- and un- immunized children about their difficulties and issues with childhood immunization.

Tuberculosis :: UA researchers identify new adherence factor, Pili, produced by tuberculosis

Researchers at the University of Arizona College of Medicine?s Department of Immunobiology have discovered that the agent that causes tuberculosis (TB), Mycobacterium tuberculosis, produces a new type of virulence factor called Mycobacterium Tuberculosis Pili (MTP). Their findings suggest that MTP could be a promising, new TB-vaccine candidate. Worldwide, three million people die each year from tuberculosis and an estimated 1.2 billion are infected with the bacteria.

Hepatitis :: Vaccine 95.5% effective against neglected hepatitis E

A new candidate vaccine against hepatitis E, developed collaboratively by GlaxoSmithKline (GSK) and the Walter Reed Army Institute of Research (WRAIR), was found to be 95.5% effective in a Phase Two trial, according to a study to be published in the New England Journal of Medicine.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack